Citadel Advisors
CELU icon

Citadel Advisors’s Celularity CELU Stock Holding History

Citadel Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,800
Closed -$32.7K – 12773
2025
Q3 		$32.7K Buy
+15,800
New +$44.2K ﹤0.01% 12377
2025
Q2 		– Sell
-12,800
Closed -$22.1K – 12745
2025
Q1 		$22.1K Sell
12,800
-11,200
-47% -$21.2K ﹤0.01% 13070
2024
Q4 		$49.9K Buy
24,000
+23,800
+11,900% +$56.8K ﹤0.01% 12393
2024
Q3 		$594 Sell
200
-1,400
-88% -$4.13K ﹤0.01% 13988
2024
Q2 		$5.01K Sell
1,600
-1,210
-43% -$4.2K ﹤0.01% 13438
2024
Q1 		$14.7K Buy
+2,810
New +$11.6K ﹤0.01% 13226
2023
Q4 		– Sell
-260
Closed -$577 – 14335
2023
Q3 		$577 Hold
260
– – ﹤0.01% 14023
2023
Q2 		$1.39K Hold
260
– – ﹤0.01% 13943
2023
Q1 		$1.61K Sell
260
-110
-30% -$885 ﹤0.01% 14271
2022
Q4 		$4.77K Buy
+370
New +$6.82K ﹤0.01% 14067
2022
Q1 		– Sell
-2,110
Closed -$108K – 13663
2021
Q4 		$108K Sell
2,110
-2,250
-52% -$144K ﹤0.01% 12639
2021
Q3 		$309K Buy
+4,360
New +$352K ﹤0.01% 11012
2021
Q2 		– Sell
-1,530
Closed -$154K – 13716
2021
Q1 		$154K Buy
+1,530
New +$157K ﹤0.01% 11996

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Citadel Advisors's CELU Position: Q2 2026 in Review

Citadel Advisors opened a new position in Celularity (CELU) in Q2 2026: 99,054 shares worth $59.2K. The stake represents ﹤0.01% of the portfolio and ranks #13040 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CELU as recently as Q4 2025.

Citadel Advisors first reported a position in CELU in Q1 2021 and has held it in 13 quarters since. The position peaked at $3.16M in Q1 2021. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Citadel Advisors held 99,054 shares of Celularity worth $59.2K as of Q2 2026.
  • Celularity was a new Citadel Advisors position in Q2 2026.
  • Celularity made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13040 holding.
  • Citadel Advisors first reported a position in Celularity in Q1 2021 and has held it in 13 quarters since.
  • Citadel Advisors's Celularity position peaked at $3.16M in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.